►Home ►Site Index
TOPIGEN PHARMACEUTICALS APPOINTS MARK PARRY-BILLINGS, PH.D., AS CHIEF EXECUTIVE OFFICER
TOPIGEN PHARMACEUTICALS COMPLETES ENROLLMENT OF PHASE II CLINICAL STUDY OF TPI ASM8 IN ASTHMA
TOPIGEN PHARMACEUTICALS TO PRESENT AT THE BIO 2008 INTERNATIONAL CONVENTION
TOPIGEN PHARMACEUTICALS APPOINTS JEREMY CURNOCK COOK TO ITS BOARD OF DIRECTORS
TOPIGEN PHARMACEUTICALS TO PARTICIPATE AT UPCOMING MEDICAL CONFERENCES
TOPIGEN PHARMACEUTICALS ANNOUNCES MANAGEMENT CHANGES
TOPIGEN PHARMACEUTICALS INITIATES EUROPEAN PHASE II CLINICAL STUDY OF TPI ASM8 IN PATIENTS WITH ASTHMA
Archives 2007 Archives 2006 Archives 2005